Interstitial Lung Disease Trial, Recruiting NCT06948916 Sponsor: Gazi University Condition: Interstitial Lung Disease
Back to Interstitial Lung Disease

Interstitial Lung Disease Trial, Recruiting

NCT06948916
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with interstitial lung disease (a group of conditions that cause scarring or inflammation in the lungs) based on recognised international diagnostic guidelines
  • People who are between 18 and 75 years of age
  • People who have had a lung infection in the past month
  • People who are willing to take part in the study voluntarily

Who may not be able to join:

  • People who have had a sudden worsening of their lung condition or a respiratory infection in the last four weeks
  • People who have an obstructive lung condition, such as asthma or chronic obstructive pulmonary disease (COPD)
  • People who have a condition affecting their nervous system, muscles, bones, or general physical ability
  • People who have taken part in a structured, planned exercise program within the last three months
  • People who have a cognitive impairment (such as memory or thinking difficulties) that would make it hard to understand or follow exercise testing instructions
  • People for whom exercise testing is considered medically unsafe according to American Sports Medicine Association guidelines (confirm with trial site)
  • People who have cancer, kidney disease, or liver disease
  • People who have aortic stenosis (a narrowing of a major heart valve), complex irregular heart rhythms, or an aortic aneurysm (a bulge in the main artery from the heart)
  • People who have serious heart or cardiovascular conditions, including uncontrolled high blood pressure, uncontrolled diabetes, heart failure, or significant irregular heart rhythms

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Meral BOŞNAK GÜÇLÜ, Prof. Dr., Gazi University

Phone: +903122162647

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Gazi University
Registry
ClinicalTrials.gov
Start date
12 December 2024
Est. completion
12 July 2025

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Upper extremity functional exercise capacity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov